MicroRNA Expression Profiling of Peripheral Blood Samples Predicts Resistance to First-line Sunitinib in Advanced Renal Cell Carcinoma Patients

MicroRNA Expression Profiling of Peripheral Blood Samples Predicts Resistance to First-line Sunitinib in Advanced Renal Cell Carcinoma Patients

Anti-angiogenic therapy benefits many patients with advanced renal cell carcinoma (RCC), but there is still a need for predictive markers that help in selecting the best therapy for individual patients. MicroRNAs (miRNAs) regulate cancer cell behavior and may be attractive biomarkers for prognosis a...

Full description

Bibliographic Details
Main Authors: Angelo Gámez-Pozo, Luis M. Antón-Aparicio, Cristina Bayona, Pablo Borrega, María I. Gallegos Sancho, Rocío García-Domínguez, Teresa de Portugal, Manuel Ramos-Vázquez, Ramón Pérez-Carrión, María V. Bolós, Rosario Madero, Iker Sánchez-Navarro, Juan A. Fresno Vara, Enrique Espinosa Arranz
Format: Article
Language:English
Published: Elsevier 2012-12-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558612800510

Internet

http://www.sciencedirect.com/science/article/pii/S1476558612800510

Similar Items